Pace / Rupp / Finch Biofilms, Infection, and Antimicrobial Therapy

Erscheinungsjahr 2005
ISBN: 978-1-4200-2823-2
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 512 Seiten

Rather than existing in a planktonic or free-living form, evidence indicates that microbes show a preference for living in a sessile form within complex communities called biofilms. Biofilms appear to afford microbes a survival advantage by optimizing nutrition, offering protection against hostile elements, and providing a network for cell-to-cell signaling and genetic exchange. Biofilms, Infection, and Antimicrobial Therapy provides an in-depth exploration of biofilms, offering broad background information, as well a detailed look at the serious concerns to which biofilm-associated infections give rise. Prosthetic device infections, such as those involving artificial heart valves, intravascular catheters, or prosthetic joints, are prime examples of biofilm-associated infections. With the increasing use of such devices in the modern practice of medicine, the prevalence of these infections is expected to increase. Unfortunately, one of the most troubling characteristics of microbes found in biofilms is a profound resistance to antimicrobial agents. As biofilm-associated infections are particularly difficult to treat, they result in significant mortality, morbidity, and increased economic burden. Clearly, a better understanding of the pathogenesis of these infections and improved means for prevention and treatment are urgently needed! InBiofilms, Infection, and Antimicrobial Therapy, Drs Pace, Rupp, and Finch assemble the contributions of more than 50 of the world’s leading authorities on microbial biofilms who present recent findings on antibacterial tolerance and bacterial persistence associated with biofilms and discuses the implications of those findings with regard to human health. They explore the molecular mechanisms of bacterial adherence, biofilm formation, regulation of biofilm maintenance, and cell-to-cell communication and present the latest information on various treatment protocols that should aid physicians in the treatment of these refractory and often difficult-to-treat infections.

Zielgruppe

Microbiologists working in the healthcare field (infectious disease i.e. clinical microbiology, antibiotics, vaccines, consumer products, and related specialties), infectious disease physicians, animal health specialists such as veterinarians, and microbial pathogeneticists

Autoren/Hrsg.

Pace, John L.

Rupp, Mark E.

Finch, Roger G.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Naturwissenschaften Biowissenschaften Molekularbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten

Inhaltsverzeichnis

SECTION I Biofilms: Background, Significance, and Roles of Catheters and Indwelling Devices
Microbial Biofilms; Xiuping Jiang and John L. Pace
Economic Impact of Biofilms on Treatment Costs; John G. Thomas, Isaiah Litton, and Harald Rinde
Biofilm-Related Indwelling Medical Device Infections; Matthew K. Schinabeck and Mahmoud A. Ghannoum
Medical Device Composition and Biological Secretion Influences on Biofilm Formation; Sean P. Gorman and David S. Jones
SECTION II Biofilm-Forming Pathogens
Role of Biofilms in Infections Caused by Escherichia coli; Grégory Jubelin, Corinne Dorel, and Philippe Lejeune
Staphylococcus aureus Biofilms; Julie M. Higashi and Paul M. Sullam
Coagulase-Negative Staphylococci; Dietrich Mack, Matthias A. Horstkotte, Holger Rohde, and Johannes K.-M. Knobloch
Pseudomonas aeruginosa Biofilm Infections in Cystic Fibrosis; Andrea Smiley and Daniel J. Hassett Candida; Stephen Hawser and Khalid Islam
SECTION III Emerging Issues, Assays, and Models
Current Perspectives on the Regulation of the ica Operon and Biofilm Formation in Staphylococcus epidermidis; Paul D. Fey and Luke D. Handke
Cell-to-Cell Communication in Bacteria; Kenneth D. Tucker and Luciano Passador
Persisters: Specialized Cells Responsible for Biofilm Tolerance to Antimicrobial Agents; Kim Lewis, Amy L. Spoering, Niilo Kaldalu, Iris Keren, and Devang Shah
Minimal Biofilm Eradication Concentration (MBEC) Assay: Susceptibility Testing for Biofilms; Howard Ceri, Merle E. Olson, Douglas W. Morck, and Douglas G. Storey
Environmental Cues Regulate Virulence and Biofilm Formation; John L. Pace and Steven M. Frey
In Vivo Models for the Study of Biomaterial-Associated Infection by Biofilm-Forming Staphylococci; Luke D. Handke and Mark E. Rupp
Host Response to Biofilms; Susan Meier-Davis
SECTION IV Overview of Antiinfective Agents and Clinical Therapy
Pharmacodynamics and the Treatment of IMD-Related Infections; Roger Finch and Sarah Gander
Protein Synthesis Inhibitors, Fluoroquinolones, and Rifampin for Biofilm Infections; Steven L. Barriere
•-Lactams for the Treatment of Biofilm-Associated Infections; Ingrid L. Dodge, Karen Joy Shaw, and Karen Bush
Glycopeptide Antibacterials and the Treatment of Biofilm-Related Infections; John L. Pace, Roasaire Verna, and Jan Verhoef
Antibiotic Resistance in Biofilms; Nafsika H. Georgopapadakou
Treatment Protocols for Infections of Vascular Catheters; Russell E. Lewis and Issam I. Raad
Treatment Protocols for Bacterial Endocarditis and Infection of Electrophysiologic Cardiac Devices; Martin E. Stryjewski and G. Ralph Corey
Treatment Protocol of Infections of Orthopedic Devices; Vera Antonios, Elie Berbari, and Douglas Osmon
Index.